Article Versions Notes

Haque M, Li J, Huang Y-H, Almowaled M, Barger CJ, Karpf AR, Wang P, Chen W, Turner SD, Lai R. NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma. Cancers. 2019; 11(8):1119. https://doi.org/10.3390/cancers11081119

Haque, Moinul, Jing Li, Yung-Hsing Huang, Meaad Almowaled, Carter J. Barger, Adam R. Karpf, Peng Wang, Will Chen, Suzanne D. Turner, and Raymond Lai. 2019. "NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma" Cancers 11, no. 8: 1119. https://doi.org/10.3390/cancers11081119

Haque, M., Li, J., Huang, Y. -H., Almowaled, M., Barger, C. J., Karpf, A. R., Wang, P., Chen, W., Turner, S. D., & Lai, R. (2019). NPM-ALK Is a Key Regulator of the Oncoprotein FOXM1 in ALK-Positive Anaplastic Large Cell Lymphoma. Cancers, 11(8), 1119. https://doi.org/10.3390/cancers11081119